Ralph R. Weichselbaum

65.8k total citations · 22 hit papers
707 papers, 48.4k citations indexed

About

Ralph R. Weichselbaum is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ralph R. Weichselbaum has authored 707 papers receiving a total of 48.4k indexed citations (citations by other indexed papers that have themselves been cited), including 274 papers in Oncology, 244 papers in Molecular Biology and 182 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ralph R. Weichselbaum's work include Head and Neck Cancer Studies (76 papers), Cancer Immunotherapy and Biomarkers (64 papers) and Advanced Radiotherapy Techniques (60 papers). Ralph R. Weichselbaum is often cited by papers focused on Head and Neck Cancer Studies (76 papers), Cancer Immunotherapy and Biomarkers (64 papers) and Advanced Radiotherapy Techniques (60 papers). Ralph R. Weichselbaum collaborates with scholars based in United States, China and Japan. Ralph R. Weichselbaum's co-authors include Michael A. Beckett, Everett E. Vokes, Yang‐Xin Fu, Donald Küfe, Hua Liang, Wenbin Lin, Byron Burnette, Liufu Deng, Samuel Hellmän and Thomas E. Darga and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ralph R. Weichselbaum

695 papers receiving 47.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Head and Neck Cancer

1993 1.8k citations Ralph R. Weichselbaum et al. profile →
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice

2014 1.6k citations Hua Liang, Byron Burnette et al. profile →
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

2014 1.5k citations Hua Liang, Byron Burnette et al. profile →
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

2009 1.1k citations Youjin Lee, Sogyong Auh et al. Blood profile →
Accurate Three-Dimensional Registration of CT, PET, and/or MR Images of the Brain

1989 807 citations Charles A. Pelizzari, Ralph R. Weichselbaum et al. profile →
Radiotherapy and immunotherapy: a beneficial liaison?

2017 781 citations Ralph R. Weichselbaum, Hua Liang et al. profile →
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells

2019 737 citations Xiaona Huang, Ralph R. Weichselbaum et al. profile →
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

1999 723 citations Michael A. Beckett, Helena J. Mauceri et al. profile →
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity

2011 686 citations Byron Burnette, Hua Liang et al. Cancer Research profile →
Oligometastases revisited

2011 682 citations Ralph R. Weichselbaum et al. profile →
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy

2016 668 citations Ralph R. Weichselbaum et al. profile →
Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications

2018 615 citations Ralph R. Weichselbaum et al. profile →
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.

1995 612 citations Ralph R. Weichselbaum et al. profile →
Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy

2018 518 citations Charles A. Pelizzari, Yang‐Xin Fu et al. profile →
Chlorin-Based Nanoscale Metal–Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy

2016 450 citations Ralph R. Weichselbaum et al. profile →
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

2018 434 citations Theodore Karrison, Sean P. Pitroda et al. profile →
Photodynamic Therapy Mediated by Nontoxic Core–Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer

2016 411 citations Ralph R. Weichselbaum et al. profile →
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling

2020 295 citations Ralph R. Weichselbaum, Yang‐Xin Fu et al. profile →
Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade

2021 220 citations Hua Liang, Ralph R. Weichselbaum et al. profile →
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration

2022 154 citations Hua Liang, Xiaona Huang et al. profile →
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy

2024 82 citations Ralph R. Weichselbaum et al. profile →
Radiotherapy, immunity, and immune checkpoint inhibitors

2024 58 citations Sean P. Pitroda, Ralph R. Weichselbaum et al. profile →

Peers

Countries citing papers authored by Ralph R. Weichselbaum

Since Specialization

Citations

This map shows the geographic impact of Ralph R. Weichselbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph R. Weichselbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph R. Weichselbaum more than expected).

Fields of papers citing papers by Ralph R. Weichselbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph R. Weichselbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph R. Weichselbaum. The network helps show where Ralph R. Weichselbaum may publish in the future.

Co-authorship network of co-authors of Ralph R. Weichselbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph R. Weichselbaum. A scholar is included among the top collaborators of Ralph R. Weichselbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph R. Weichselbaum. Ralph R. Weichselbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A universal chimeric antigen receptor (CAR)–fragment antibody binder (FAB) split system for cancer immunotherapy 2025 ·Science Advances ·Ainhoa Arina, Edwin Araúz, Elham Masoumi, (unknown), Annika Sääf, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ralph R. Weichselbaum, Anthony A. Kossiakoff	0
2	Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma 2019 ·Cancer Research ·David J. Voce, Giovanna M. Bernal, Longtao Wu, Clayton D. Crawley, Wei Zhang, Nassir M. Mansour, Kirk E. Cahill, (unknown), Abhineet Uppal, David R. Raleigh, Rubén Spretz, Luis Núñez, Gustavo Larsen, Nikolai N. Khodarev, Ralph R. Weichselbaum, Bakhtiar Yamini	78
3	STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability 2018 ·Cancer Research ·Diana Rose E. Rañoa, Ryan C. Widau, Stephen Mallon, Akash D. Parekh, Claudia M. Nicolae, Xiaona Huang, Michael J. Bolt, Ainhoa Arina, Renate Parry, Stephen J. Kron, George‐Lucian Moldovan, Nikolai N. Khodarev, Ralph R. Weichselbaum	75
4	DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs 2018 ·Cancer Research ·Go Oshima, (unknown), Michael J. Bolt, Alexandre Chlenski, (unknown), Jessica M.S. Jutzy, Neha Biyani, Mitchell C. Posner, Sean P. Pitroda, Ralph R. Weichselbaum, Nikolai N. Khodarev	39
5	Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1–Resistant Tumors Leading to Tumor Eradication 2017 ·Cancer Immunology Research ·Ainhoa Arina, Theodore Karrison, (unknown), Karin Schreiber, Ralph R. Weichselbaum, Hans Schreiber	14
6	Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer 2017 ·Clinical Cancer Research ·Sean P. Pitroda, Riyue Bao, Jorge Andrade, Ralph R. Weichselbaum, Philip P. Connell	13
7	HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation 2017 ·Molecular Cancer Therapeutics ·Elena V. Efimova, (unknown), Edwardine Labay, Helena J. Mauceri, Amy C. Flor, (unknown), Harold G. Sutton, Ralph R. Weichselbaum, Stephen J. Kron	43
8	Decoy Receptor DcR1 Is Induced in a p50/Bcl3–Dependent Manner and Attenuates the Efficacy of Temozolomide 2015 ·Cancer Research ·Nassir M. Mansour, Giovanna M. Bernal, Longtao Wu, Clayton D. Crawley, Kirk E. Cahill, David J. Voce, Irina V. Balyasnikova, Wei Zhang, Rubén Spretz, Luis Núñez, Gustavo Larsen, Ralph R. Weichselbaum, Bakhtiar Yamini	15
9	Linking Cancer Metabolism to DNA Repair and Accelerated Senescence 2015 ·Molecular Cancer Research ·Elena V. Efimova, Satoe Takahashi, (unknown), Ding Wu, Edwardine Labay, Olesya A. Ulanovskaya, Ralph R. Weichselbaum, Sergey A. Kozmin, Stephen J. Kron	42
10	Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation 2015 ·Clinical Cancer Research ·Matthias Leisegang, Boris Engels, Karin Schreiber, Poh Yin Yew, Kazuma Kiyotani, Christian Idel, Ainhoa Arina, Jaikumar Duraiswamy, Ralph R. Weichselbaum, Wolfgang Uckert, Yusuke Nakamura, Hans Schreiber	59
11	The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors 2014 ·Cancer Research ·Jennifer M. Mason, Hillary L. Logan, Brian Budke, Megan Wu, Michał Pawłowski, Ralph R. Weichselbaum, Alan P. Kozikowski, Douglas K. Bishop, Philip P. Connell	41
12	EPR Oxygen Images Predict Tumor Control by a 50% Tumor Control Radiation Dose 2013 ·Cancer Research ·Martyna Elas, (unknown), (unknown), (unknown), (unknown), (unknown), Eugene D. Barth, Boris Epel, Samuel M. Rubinstein, Charles A. Pelizzari, Ralph R. Weichselbaum, Howard J. Halpern	50
13	A Survivin-Associated Adaptive Response in Radiation Therapy 2013 ·Cancer Research ·David J. Grdina, Jeffrey S. Murley, Richard C. Miller, Helena J. Mauceri, Harold G. Sutton, Jian Jian Li, Gayle E. Woloschak, Ralph R. Weichselbaum	44
14	Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth 2012 ·Clinical Cancer Research ·Nikolai N. Khodarev, Bernard Roizman, Ralph R. Weichselbaum	154
15	Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers 2012 ·Clinical Cancer Research ·Karin Schreiber, Ainhoa Arina, Boris Engels, Michael T. Spiotto, John Sidney, Alessandro Sette, Theodore Karrison, Ralph R. Weichselbaum, Donald A. Rowley, Hans Schreiber	21
16	Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy 2010 ·Cancer Research ·Yuru Meng, Michael A. Beckett, Hua Liang, Helena J. Mauceri, Nico van Rooijen, Kenneth S. Cohen, Ralph R. Weichselbaum	144
17	Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors 2010 ·Cancer Research ·Elena V. Efimova, Helena J. Mauceri, Daniel W. Golden, Edwardine Labay, Vytautas P. Bindokas, Thomas E. Darga, Chaitali Chakraborty, (unknown), Clayton D. Crawley, Harold G. Sutton, Stephen J. Kron, Ralph R. Weichselbaum	98
18	Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment breakdown → 2009 ·Blood ·Youjin Lee, Sogyong Auh, Yugang Wang, Byron Burnette, Yang Wang, Yuru Meng, Michael A. Beckett, Rohit Sharma, Robert Chin, Tony Tu, Ralph R. Weichselbaum, Yang‐Xin Fu	1050
19	Inhibition of Nuclear Factor-κB Activity by Temozolomide Involves O 6-Methylguanine–Induced Inhibition of p65 DNA Binding 2007 ·Cancer Research ·Bakhtiar Yamini, Xiaohong Yu, M. Eileen Dolan, Michael H. Wu, Donald Küfe, Ralph R. Weichselbaum	33
20	Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation 2005 ·Cancer Research ·(unknown), Mitchell C. Posner, James O. Park, Thomas E. Darga, Masha Kocherginsky, Theodore Karrison, John Hart, Kerrington D. Smith, James J. Mezhir, Ralph R. Weichselbaum, Nikolai N. Khodarev	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact